$0.2174375 per shareSeries 2 - $0.4041397 per shareSeries 3 - $0.105875 per shareSeries 4 - $0.3642493 per share For the period up to but excluding July 30, 2023, payable on July 31, 2023, to. | April 28, 2023
This release includes, in Appendix 1, for comparison purposes, the Financial Statements excluding the effect of the IFRS16. Financial Calendar : . | April 26, 2023
EARNINGS/SALES RELEASESQ1 sales, marginally ahead of street estimates, were impacted by the declining demand for COVID-19 testing, as expected. However, excluding COVID-19, both Pharmaceuticals and. | April 26, 2023